179 related articles for article (PubMed ID: 33565643)
21. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
Mederacke YS; Kirstein MM; Großhennig A; Marhenke S; Metzler F; Manns MP; Vogel A; Mederacke I
Aliment Pharmacol Ther; 2020 Jun; 51(11):1160-1168. PubMed ID: 32323349
[TBL] [Abstract][Full Text] [Related]
22. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
23. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis.
Israelsen M; Juel HB; Detlefsen S; Madsen BS; Rasmussen DN; Larsen TR; Kjærgaard M; Fernandes Jensen MJ; Stender S; Hansen T; Krag A; Thiele M;
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1784-1794.e9. PubMed ID: 33279778
[TBL] [Abstract][Full Text] [Related]
24. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
[TBL] [Abstract][Full Text] [Related]
25. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
Yang J; Trépo E; Nahon P; Cao Q; Moreno C; Letouzé E; Imbeaud S; Gustot T; Deviere J; Debette S; Amouyel P; Bioulac-Sage P; Calderaro J; Ganne-Carrié N; Laurent A; Blanc JF; Guyot E; Sutton A; Ziol M; Zucman-Rossi J; Nault JC
Int J Cancer; 2019 Feb; 144(3):533-544. PubMed ID: 30289982
[TBL] [Abstract][Full Text] [Related]
26. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.
Oliveira AIN; Malta FM; Zitelli PMY; Salles APM; Gomes-Gouvea MS; Nastri ACS; Pinho JRR; Carrilho FJ; Oliveira CP; Mendes-Corrêa MC; Pessoa MG; Mazo DF
BMC Gastroenterol; 2021 Feb; 21(1):81. PubMed ID: 33622266
[TBL] [Abstract][Full Text] [Related]
27. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
Lee KJ; Moon JS; Kim NY; Ko JS
Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745
[TBL] [Abstract][Full Text] [Related]
28. NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study.
Xia M; Ma S; Huang Q; Zeng H; Ge J; Xu W; Wu Q; Wu L; Li X; Ma H; Chen L; Li Q; Aleteng Q; Hu Y; He W; Pan B; Lin H; Zheng Y; Wang S; Tang H; Gao X
Aliment Pharmacol Ther; 2022 Mar; 55(6):705-721. PubMed ID: 35023183
[TBL] [Abstract][Full Text] [Related]
29. Association of PNPLA3 rs738409 and TM6SF2 rs58542926 with health services utilization in a population-based study.
Köpp J; Fleßa S; Lieb W; Markus MRP; Teumer A; Homuth G; Wallaschofski H; Marschall P; Völzke H; Baumeister SE
BMC Health Serv Res; 2016 Feb; 16():41. PubMed ID: 26847197
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
31. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
32. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study.
Vespasiani-Gentilucci U; Dell'Unto C; De Vincentis A; Baiocchini A; Delle Monache M; Cecere R; Pellicelli AM; Giannelli V; Carotti S; Galati G; Gallo P; Valentini F; Del Nonno F; Rosati D; Morini S; Antonelli-Incalzi R; Picardi A
Can J Gastroenterol Hepatol; 2018; 2018():7564835. PubMed ID: 29732362
[TBL] [Abstract][Full Text] [Related]
33. APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis.
Tong M; Wang F
IUBMB Life; 2020 Aug; 72(8):1757-1764. PubMed ID: 32525256
[TBL] [Abstract][Full Text] [Related]
34. Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.
Akuta N; Kawamura Y; Arase Y; Suzuki F; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Suzuki Y; Ikeda K; Kumada H
Gut Liver; 2016 May; 10(3):437-45. PubMed ID: 26610348
[TBL] [Abstract][Full Text] [Related]
35. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.
Zhang Y; Guo T; Yang F; Mao Y; Li L; Liu C; Sun Q; Li Y; Huang J
Hepatol Int; 2018 Sep; 12(5):429-437. PubMed ID: 30132178
[TBL] [Abstract][Full Text] [Related]
36. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
[TBL] [Abstract][Full Text] [Related]
37. Penetrance of the C28Y/C282Y genotype of the HFE gene.
Asberg A; Hveem K; Kannelønning K; Irgens WØ
Scand J Gastroenterol; 2007 Sep; 42(9):1073-7. PubMed ID: 17710673
[TBL] [Abstract][Full Text] [Related]
38. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
39. Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Seko Y; Yamaguchi K; Tochiki N; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Umemura A; Moriguchi M; Tanaka S; Mori K; Okanoue T; Itoh Y
Liver Int; 2020 Jul; 40(7):1686-1692. PubMed ID: 32342668
[TBL] [Abstract][Full Text] [Related]
40. PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study.
Rauff B; Alzahrani B; Chudhary SA; Nasir B; Mahmood S; Bhinder MA; Faheem M; Amar A
BMC Gastroenterol; 2022 Aug; 22(1):401. PubMed ID: 36028802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]